Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model.

Abstract

A single injection of SUN9216 was effective in recanalizing the vessel and reducing the area of cerebral infarction.